» Articles » PMID: 37248420

Monocyte-derived IL-6 Programs Microglia to Rebuild Damaged Brain Vasculature

Overview
Journal Nat Immunol
Date 2023 May 29
PMID 37248420
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebrovascular injury (CVI) is a common pathology caused by infections, injury, stroke, neurodegeneration and autoimmune disease. Rapid resolution of a CVI requires a coordinated innate immune response. In the present study, we sought mechanistic insights into how central nervous system-infiltrating monocytes program resident microglia to mediate angiogenesis and cerebrovascular repair after an intracerebral hemorrhage. In the penumbrae of human stroke brain lesions, we identified a subpopulation of microglia that express vascular endothelial growth factor A. These cells, termed 'repair-associated microglia' (RAMs), were also observed in a rodent model of CVI and coexpressed interleukin (IL)-6Ra. Cerebrovascular repair did not occur in IL-6 knockouts or in mice lacking microglial IL-6Ra expression and single-cell transcriptomic analyses revealed faulty RAM programming in the absence of IL-6 signaling. Infiltrating CCR2 monocytes were the primary source of IL-6 after a CVI and were required to endow microglia with proliferative and proangiogenic properties. Faulty RAM programming in the absence of IL-6 or inflammatory monocytes resulted in poor cerebrovascular repair, neuronal destruction and sustained neurological deficits that were all restored via exogenous IL-6 administration. These data provide a molecular and cellular basis for how monocytes instruct microglia to repair damaged brain vasculature and promote functional recovery after injury.

Citing Articles

Unlocking the therapeutic potential of tumor-derived EVs in ischemia-reperfusion: a breakthrough perspective from glioma and stroke.

Hao Z, Guan W, Wei W, Li M, Xiao Z, Sun Q J Neuroinflammation. 2025; 22(1):84.

PMID: 40089793 DOI: 10.1186/s12974-025-03405-7.


Inhibition of IL-6 trans-signaling promotes post-stroke functional recovery in a sex and dose-dependent manner.

Hall C, Nguyen D, Mendoza K, Tan C, Chauhan A J Neuroinflammation. 2025; 22(1):52.

PMID: 40011978 PMC: 11866694. DOI: 10.1186/s12974-025-03365-y.


Mechanism of disturbed endothelial cell function on angiogenesis following ischemic brain stroke (Review).

Gong R, Tan J, Liu G, Liu X, Ma L, Shi S Exp Ther Med. 2025; 29(4):61.

PMID: 39991719 PMC: 11843205. DOI: 10.3892/etm.2025.12811.


The interaction between central and peripheral immune systems in methamphetamine use disorder: current status and future directions.

Shi S, Sun Y, Zan G, Zhao M J Neuroinflammation. 2025; 22(1):40.

PMID: 39955589 PMC: 11829452. DOI: 10.1186/s12974-025-03372-z.


Mechanisms and environmental factors shaping the ecosystem of brain macrophages.

Penati S, Brioschi S, Cai Z, Han C, Colonna M Front Immunol. 2025; 16:1539988.

PMID: 39925814 PMC: 11802581. DOI: 10.3389/fimmu.2025.1539988.


References
1.
Uyttenhove C, Coulie P, Van Snick J . T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med. 1988; 167(4):1417-27. PMC: 2188915. DOI: 10.1084/jem.167.4.1417. View

2.
Roth T, Nayak D, Atanasijevic T, Koretsky A, Latour L, McGavern D . Transcranial amelioration of inflammation and cell death after brain injury. Nature. 2013; 505(7482):223-8. PMC: 3930079. DOI: 10.1038/nature12808. View

3.
Narantuya D, Nagai A, Sheikh A, Masuda J, Kobayashi S, Yamaguchi S . Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. PLoS One. 2010; 5(7):e11746. PMC: 2909196. DOI: 10.1371/journal.pone.0011746. View

4.
Van Snick J . Interleukin-6: an overview. Annu Rev Immunol. 1990; 8:253-78. DOI: 10.1146/annurev.iy.08.040190.001345. View

5.
Nayak D, Roth T, McGavern D . Microglia development and function. Annu Rev Immunol. 2014; 32:367-402. PMC: 5001846. DOI: 10.1146/annurev-immunol-032713-120240. View